Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies (Q28139557)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: December 1999)
edit
Language Label Description Also known as
English
Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies
scientific article (publication date: December 1999)

    Statements

    Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies (English)
    0 references
    C L Chen
    0 references
    A Levine
    0 references
    A Rao
    0 references
    K O'Neill
    0 references
    Y Messinger
    0 references
    D E Myers
    0 references
    F Goldman
    0 references
    C Hurvitz
    0 references
    J T Casper
    0 references
    F M Uckun
    0 references
    December 1999
    0 references
    39
    0 references
    12
    0 references
    1248-55
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit